Biote (BTMD) Restructuring Costs (2021 - 2022)
Biote (BTMD) recorded quarterly Restructuring Costs of $1.2 million in Q1 2022, down 49.15% quarter-over-quarter from $2.3 million in Q4 2021, and up 1932.73% on a YoY basis from $58560.0 in Q1 2021.
Biote (BTMD) Restructuring Costs (2021 - 2022) Analysis & Trends
Biote's Restructuring Costs history runs 2 years deep, the most recent figure standing at $1.2 million for Q1 2022.
- In Q1 2022, Restructuring Costs rose 1932.73% year-over-year to $1.2 million; the TTM figure through Mar 2022 stood at $4.3 million (changed N/A YoY), while the FY2021 annual figure was $3.1 million, changed N/A from the prior year.
- Restructuring Costs was $1.2 million for Q1 2022 at Biote, down from $2.3 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $2.3 million in Q4 2021 to a low of $58560.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn |
| 10 | Biote | 67.42 Mn | 70.24 Mn | 30.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 1.19 Mn |
| Dec 31, 2021 | 2.34 Mn |
| Sep 30, 2021 | 262,487.00 |
| Jun 30, 2021 | 459,768.00 |
| Mar 31, 2021 | 58,560.00 |